Cariprazine

Drug Class or Subclass
Generic
Cariprazine
Brand Name
Vraylar
Import ID
82
Displaying 1 - 5 of 5
Interaction Color Code Clinical Bottom Line Clinical Effects Drug 1 effect Drug 2 dose Drug 2 effect Management
Darunavir Cariprazine 873 Yellow: Adjust dosing Adjust dosing to avoid increased levels of cariprazine

Potential for increased risk of cariprazine adverse effects

If starting cariprazine in a patient on a protease inhibitor, administer cariprazine 1.5 mg on Day 1 and Day 3, with no dose given on Day 2. From Day 4 onward, administer cariprazine 1.5 mg daily. Dose may be increased to a maximum of cariprazine 3 mg daily. If starting a protease inhibitor for a patient already taking cariprazine 3-6mg, reduce dose by half. For patients taking cariprazine 4.5 mg daily, reduced cariprazine dose to 1.5 - 3 mg daily. For patients taking cariprazine 1.5 mg daily, reduce to cariprazine 1.5 mg every other day. If PI is withdrawn, cariprazine dose may need to be increased.

Nevirapine Cariprazine 627 Red: Avoid combination Do not coadminister: potientially reduced levels of cariprazine

Potential decreased cariprazine effects

Contraindicated. Use alternative agents.

Etravirine Cariprazine 548 Red: Avoid combination Do not coadminister: potientially reduced levels of cariprazine

Potential decreased cariprazine effects

Contraindicated. Use alternative agents.

Efavirenz Cariprazine 444 Red: Avoid combination Do not coadminister: Reduced levels of cariprazine

Decreased cariprazine levels

Avoid combination and use alternative agents

Elvitegravir Cariprazine 158 Yellow: Adjust dosing Adjust dosing to avoid increased levels of cariprazine

Potential for increased risk of cariprazine adverse effects

If patient is receiving EVG / c, administer cariprazine 1.5 mg on Day 1 and Day 3, with no dose given on Day 2. From Day 4 onward, administer cariprazine 1.5 mg daily. Dose can be increased to a maximum dose of 3 mg daily. If EVG / c is withdrawn, cariprazine dose may need to be increased. If patient is receiving cariprazine 3 mg or 6 mg daily, reduce cariprazine dose by half. For patients taking cariprazine 4.5 mg daily, the dose should be reduced to 1.5 mg or 3 mg daily. For patients taking cariprazine 1.5 mg daily, change to 1.5 mg every other day. If EVG / c is withdrawn, cariprazine dose may need to be increased.